BioNTech SE

22UA XETRA / Francfort Healthcare & Biotech Germany
76.40
2.98 %

BioNTech is a biotechnology company focused on developing gene therapies for serious diseases, known worldwide for its COVID-19 vaccine.

Performance & Momentum

6 Months 14.16 %
1 Year 8.28 %
3 Years 22.50 %
5 Years 53.15 %

Similar stocks to BioNTech SE

Anantys Community

Be the first to share your analysis on BioNTech SE.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases